Trial Profile
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Clascoterone (Primary) ; Clascoterone (Primary)
- Indications Acne vulgaris
- Focus Pharmacodynamics
- Sponsors Cassiopea
- 01 Feb 2019 Status changed from recruiting to completed.
- 15 Feb 2017 Planned End Date changed from 1 Feb 2017 to 1 Dec 2017.
- 15 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Oct 2017.